AP402

· AP Biosciences Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AP402, covering 2025-04-25 to 2025-04-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AP402 in HER2-Positive Patients With Locally or Advanced Solid Tumors [Phase 1, Phase 2]